90 chapter 4: cardiovascular emergencies - … · 90 chapter 4: cardiovascular emergencies advanced...

1
90 CHAPTER 4: Cardiovascular Emergencies Advanced Life Support Successful treatment of cardiogenic shock involves minimizing the volume of fluid admin- istered and early consideration of a vasopressor. Treatment of Obstructive Shock The additional option for treatment of obstruc- tive shock from pneumothorax is needle tho - racostomy to decrease air tension as explained in . This technique will not remove blood, but will place the pleural space at atmospheric pres- sure, and release air tension. Rapid transport is an essential feature of field management of chest injury. Initial Assessment: Transport Decision After completing the initial assessment and beginning general treatment when appropri- ate, the prehospital professional must decide whether to go or stay on scene. If the PAT and ABCDEs are normal and the child has no history of serious illness or injury mech- anism, no anatomic abnormalities, and no pain, the child does not usually require urgent treatment or immediate transport. Take the time to get a focused history and physical exam and perform a detailed physi- cal examination (trauma) on the scene if possible. On the other hand, if the child has a serious mechanism of injury, a physiologic or anatomic abnormality, severe pain, or if the scene is not safe, transport immediately. With such patients, do the additional assess- ment and attempt specific treatment on the way to the hospital, if possible. The transport decision is sometimes dif- ficult in a child with a suspected cardiovas- Needle Thoracostomy, Procedure 22 reverse the bronchospasm of anaphylaxis (beta effect). For all children with allergic reactions associated with wheezing, adminis- ter epinephrine, 0.01 mg/kg (0.01 mL/kg) of 1:1000 solution (maximum 0.3 mg or 0.3 mL) subcutaneously (SQ). If a child has hypoperfusion with anaphylaxis, administer epinephrine by IV, using a maximum dose of 0.1 mg and a more dilute solution to decrease the possibility of an adverse drug reaction. Draw up 0.01 mg/kg (0.1 mL/kg) of the 1:10,000 epinephrine solution (maximum 0.1 mg or 1 mL of the epinephrine) and dilute the solution further with 10 mL of nor- mal saline to reduce the epinephrine concen- tration to 1:100,000. Treatment of Cardiogenic Shock If cardiogenic shock is suspected by history and/or physical assessment, transport after general noninvasive treatment. On the way to the ED, consider vascular access. If the diagnosis of cardiogenic shock is uncertain, give a cautious fluid bolus of only 10 mL/kg of crystalloid fluid, and then reassess appearance, work of breathing, capillary refill time, heart rate, and blood pressure. If there is no rhythm disturbance on the cardiac monitor, and the child remains poorly perfused after the initial fluid bolus, consider a vasopressor agent, either dobuta- mine, dopamine, or epinephrine, if the transport time is long. Start vasopressors at low doses, based on per kilogram nomo- grams, and then titrate to achieve acceptable perfusion (improved appearance and skin circulation and decreased heart rate and res- piratory rate). If the child is known to be in congestive heart failure with cardiogenic shock, avoid fluid boluses and consider vasopressor therapy as front-line treatment if perfusion is severely compromised. The major difference between treat- ment of hypovolemic, distributive, and cardiogenic shock is the amount of fluid administration and consideration of a vasopressor.

Upload: duongbao

Post on 14-Apr-2018

218 views

Category:

Documents


5 download

TRANSCRIPT

90 CHAPTER 4: Cardiovascular Emergencies

Advanced Life Support

Successful treatment of cardiogenic shockinvolves minimizing the volume of fluid admin-istered and early consideration of a vasopressor.

Treatment of ObstructiveShock

The additional option for treatment of obstruc-tive shock from pneumothorax is needle tho-racostomy to decrease air tension as explainedin .

This technique will not remove blood, but willplace the pleural space at atmospheric pres-sure, and release air tension. Rapid transport isan essential feature of field management ofchest injury.

Initial Assessment:Transport Decision

After completing the initial assessment andbeginning general treatment when appropri-ate, the prehospital professional must decidewhether to go or stay on scene. If the PATand ABCDEs are normal and the child hasno history of serious illness or injury mech-anism, no anatomic abnormalities, and nopain, the child does not usually requireurgent treatment or immediate transport.Take the time to get a focused history andphysical exam and perform a detailed physi-cal examination (trauma) on the scene ifpossible.

On the other hand, if the child has aserious mechanism of injury, a physiologicor anatomic abnormality, severe pain, or ifthe scene is not safe, transport immediately.With such patients, do the additional assess-ment and attempt specific treatment on theway to the hospital, if possible.

The transport decision is sometimes dif-ficult in a child with a suspected cardiovas-

Needle Thoracostomy, Procedure 22

reverse the bronchospasm of anaphylaxis(beta effect). For all children with allergicreactions associated with wheezing, adminis-ter epinephrine, 0.01 mg/kg (0.01 mL/kg) of 1:1000 solution (maximum 0.3 mg or 0.3 mL) subcutaneously (SQ). If a child hashypoperfusion with anaphylaxis, administerepinephrine by IV, using a maximum dose of0.1 mg and a more dilute solution to decreasethe possibility of an adverse drug reaction.Draw up 0.01 mg/kg (0.1 mL/kg) of the1:10,000 epinephrine solution (maximum0.1 mg or 1 mL of the epinephrine) anddilute the solution further with 10 mL of nor-mal saline to reduce the epinephrine concen-tration to 1:100,000.

Treatment of CardiogenicShock

If cardiogenic shock is suspected by historyand/or physical assessment, transport aftergeneral noninvasive treatment. On the wayto the ED, consider vascular access. If thediagnosis of cardiogenic shock is uncertain,give a cautious fluid bolus of only 10 mL/kgof crystalloid fluid, and then reassessappearance, work of breathing, capillaryrefill time, heart rate, and blood pressure.

If there is no rhythm disturbance on thecardiac monitor, and the child remainspoorly perfused after the initial fluid bolus,consider a vasopressor agent, either dobuta-mine, dopamine, or epinephrine, if thetransport time is long. Start vasopressors atlow doses, based on per kilogram nomo-grams, and then titrate to achieve acceptableperfusion (improved appearance and skincirculation and decreased heart rate and res-piratory rate). If the child is known to be incongestive heart failure with cardiogenicshock, avoid fluid boluses and considervasopressor therapy as front-line treatmentif perfusion is severely compromised.

The major difference between treat-ment of hypovolemic, distributive, andcardiogenic shock is the amount of fluidadministration and consideration of avasopressor.

26540_CH04_pepp.qxd 3/2/06 9:12 AM Page 90